Alterations in cathepsin L expression and trafficking have been associated with the progression and metastasis of several tumor entities. In the present study, we examined the effects of various cathepsin L antisense ( as ) phosphorothioate oligonucleotides on both the expression of cathepsin L and the invasive potential of the human osteosarcoma cell line MNNG / HOS. Seven oligonucleotides of 20 -bp length each and one random control oligonucleotide were chosen to block cathepsin L expression. Northern blot analysis demonstrated a significant reduction in cathepsin L mRNA expression by the six antisense oligonucleotides at a concentration of 10 M. Cathepsin L protein expression was reduced significantly ( 50 ± 85% ) by the antisense oligonucleotides, as compared with the controls. Adhesion to matrices of collagen I and matrigel was not affected. In in vitro motility and invasion assays performed in uncoated and precoated transwell chambers, the ability of cells to migrate through the filters was inhibited by 35 ± 75% using antisense oligonucleotides. The random control did not show any inhibitory effect. These data demonstrate that in MNNG / HOS cells cathepsin L influences cellular malignancy by promoting migration and basement membrane degradation. Cancer Gene Therapy ( 2001 ) 8, 522 ± 528
P roteolytic enzymes participating in the degradation of stromal proteins are important for the development of invasion and metastases. 1 They are synthesized as proenzymes with no or only weak proteolytic activity. The proenzymes generally are activated by limited proteolysis either through autoactivation or other proteolytic enzymes participating in a complex activation cascade. Deregulation of the cellular protease network has been shown to be responsible for the aggressive clinical behavior of several common malignancies. 2 ± 5 Cathepsin L is a lysosomal endopeptidase that belongs to the cysteine protease class. This enzyme is widely distributed and normally participates in the intralysosomal degradation of molecules taken up from the extracellular matrix. 6, 7 In tumor cells, alterations at one or more of the levels that regulate cysteine protease biosynthesis lead to an upregulation, membrane association, and secretion of cathepsin L. Extensive studies on cysteine protease expression in different cancer types, including melanoma and carcinoma of the lung, colon, prostate, and breast revealed an increased expression of cathepsin L. 8 ± 11 In some of these tumor entities, cathepsin L reached prognostic significance. 12 Besides the high number of descriptive studies on the expression of cathepsin L in tumors, there are some investigations dealing with protease inhibitors in functional in vitro assays to clarify the specific function of proteases in the metastatic process. 13 ± 16 Under consideration of the great homologies between the members of the class of cysteine proteases, it is difficult to find a specific inhibitor to block only one of these proteases. Furthermore, using synthetic inhibitors, only the catalytic activity, but no noncatalytic features, can be influenced. Antisense technologies are beneficial tools for reducing the expression of a single gene in the early steps of its biosynthesis and can be used to deduce the role of a specific protein by loss -of -function analysis. 17 The present study shows the specific inhibition of both cathepsin L mRNA and protein expression by antisense oligonucleotides in the human osteosarcoma cell line MNNG /HOS. We analyzed the efficiency of the oligonucleotide uptake and the potential toxicity of the oligonucleotides or transfection reagents. The effects of the antisense cathepsin L oligonucleotides were quantified in functional in vitro adhesion, motility, and invasion assays, representing different steps in the metastatic cascade of malignant tumors.
METHODS

Cell culture
The human osteosarcoma cell line MNNG / HOS was obtained from ATCC (CRL 1547, Rockville, MD ). Cells were grown under standard conditions in RPMI 1640 medium ( PAA, Linz, Austria ), supplemented with 10% FBS (Greiner, Frickenhausen, Germany ), antibiotics /antimycotics ( Life Technologies, Karlsruhe, Germany ) and incubated at 378C in humidified atmosphere containing 5% CO 2 . The adherent cells were detached from the culture flasks using trypsin / EDTA ( Life Technologies ). Before functional assays, 0.02% EDTA ( Sigma, Deisenhofen, Germany ) was alternatively used to avoid the destruction of cell surface antigens. Cells were counted in the Coulter Counter ZII (Coulter Immunotech, Marseille, France ).
Antisense oligonucleotides
The antisense oligonucleotides used in this study were complementary to various regions of the cathepsin L mRNA sequence and are listed in Table 1 . A random oligodeoxynucleotide was used as a control. All oligonucleotides were 20 bases in length and were protected against exonucleases and endonucleases by phosphorothioate backbones. The uptake of the oligonucleotides in the cultured cells was monitored by using fluorescein ( FITC )-labeled phosporothioate oligonucleotides. Synthesis was performed by Eurogentec (Seraing, Belgium ). 5 ) were transfected with or, at the end, without lipofectin (Life Technologies ). Using lipofectin, 1 M oligonucleotide and lipofectin ( 0± 20 g/mL) were allowed to form complexes in serum -free RPMI 1640 medium according to the manufacturer's instructions. The cells were washed twice with serum -free RPMI 1640 medium and then incubated with lipofectin /oligonucleotide for 6 hours at 378C. After incubation, cells were washed with culture medium containing 10% FBS and then incubated under normal culture conditions.
Transfection
MNNG / HOS cells (5Â10
For longer incubation periods, 10 M of oligonucleotide was added to the culture medium without a transfection reagent. The medium containing the oligonucleotides was changed every 48 hours for 1 week before the functional assays.
The uptake of the oligonucleotides was monitored by using FITC -labeled oligonucleotides, and the samples were measured using flow cytometry (FACSCalibur, Becton Dickinson, Heidelberg, Germany ) or controlled under a fluorescence confocal microscope (Zeiss, Jena, Germany ).
MTT cytotoxicity assay
The MNNG /HOS cells ( 1Â10 4 ) were seeded into 96 -well plates and incubated with the appropriate amount of antisense oligonucleotide and/ or lipofectin. MTT [3 -( 4,5-dimethylthiazol -2 -yl )-2,5-diphenyl tetrazolium bromide; Sigma ] was dissolved in PBS at 5 mg /mL and filtered for sterilization. Ten microliters of stock MTT solution was added to the wells, and plates were incubated for 2 hours at 378C. The supernatant was removed, and 100 l DMSO was added to dissolve the dark blue crystals. The color development was quantified at 562 nm on an ELISA reader ( Anthos, Cologne, Germany ). 
Northern blot analysis
Total cellular RNA was extracted from confluent cultures using TRIzol 1 reagent (Life Technologies ) according to the manufacturer's instructions, electrophoresed on 1.2% agarose ±formaldehyde gels (10 g /lane ), and blotted to Hybond N + membranes. The filters were hybridized at 658C for 4 hours using 32 P -labeled full -length cathepsin L cDNA. After stripping, the membranes were rehybridized with -actin cDNA as a semiquantitative control in densitometric analysis. Washed blots were exposed to Kodak BioMax MS -1 film ( Sigma -Aldrich, Deisenhofen, Germany ) at À 708C.
Quantification of cathepsins B, L, X, and F mRNA by real -time quantitative RT -PCR
Assays were performed on the LightCycler (Roche Diagnostics, Mannheim, Germany ). Several dilutions of plasmids containing the cDNA fragments of the different cathepsins were used as internal controls. For plasmid construction, the cDNA fragments were amplified using primers listed in Table 2 and inserted into the pCR2.1-TOPO vector (Invitrogen, Groningen, Netherlands ). The copy number of the resulting plasmids was calculated after DNA quantification.
Total RNA was extracted as described above and reversetranscribed using oligo( dT ) 12 ± 18 primers (Life Technologies ) and Omniscript reverse transcriptase (Qiagen, Hilden, , and 1 l of each primer ( 10 pmol / l). The standard temperature profile included an initial denaturation for 30 seconds at 958C, followed by 40 cycles of denaturation at 958C for 0 seconds, annealing at 54 to 648C (depending on the primers ) for 5 seconds, and an extension at 728C for 18 seconds. All oligonucleotide primers were custom synthesized by Eurogentec ( Seraing, Belgium ).
In vitro adhesion
Cellular adhesion of MNNG /HOS and the oligonucleotidetreated cells was quantified on collagen I matrices. Twentyfour well culture dishes were coated with 10 g collagen I per milliliter adhesion buffer (0.25% BSA in HBSS ) for 1 hour at 378C. Tumor cells were detached with 0.02% EDTA, and the cell number was counted. Cells were resuspended in adhesion buffer, and 1Â10 5 cells were added per well. After 45 minutes at 378C, nonadherent cells were removed by gentle washes with HBSS. Adherent cells were detached with trypsin ±EDTA solution and quantified in a Coulter Counter ZII (Coulter Immunotech ). The percentage of adherent cells was calculated from 1Â10 5 cells. All quantifications were done in triplicate. A P value of <.05 was considered significant in unpaired, two-tailed t test.
In vitro motility and invasion
Cellular invasion and motility of original and modified osteosarcoma cells were evaluated in 24-well Transwell chambers ( Costar, Bodenheim, Germany ). The upper and lower culture compartments were separated by polycarbonate filters with 8-m pore size. Before invasion assays, the polycarbonate filter was coated with 100 ng Matrigel matrix. For invasion assays, 5Â10 4 cells /well were incubated on the reconstituted basement membrane for 48 hours. In motility assays, 1Â10 5 cells / well were seeded onto the filters for 24 hours. Cells passing the filters and attaching to the lower sites of uncoated or matrigel -coated membranes were harvested by using trypsin /EDTA, and the cell number was quantified as described above. The number of migrating cells was calculated from 5Â10 4 (invasion ) and 1Â10 
RESULTS
Cellular uptake of oligonucleotides
To obtain information on the time course of oligonucleotide uptake, we tried to determine the optimal concentrations of oligonucleotides and transfection reagents. In toxicity assays, lipofectin showed a concentration -dependent, high cytotoxic effect on the MNNG / HOS cells ( Fig 1A ) , whereas the oligonucleotides alone slightly altered the cellular proliferation at concentrations of up to 10 M (Fig 1) .
To determine whether the oligonucleotides were taken up by the cells with and without adding a transfection reagent, an FITC -labeled oligonucleotide ( asCL -2 ) was added to culture medium under different conditions regarding oligonucleotide concentration, time intervals, and addition of transfection reagents ( Fig 2B ) . The efficiency of the oligonucleotide uptake into the cells was higher by adding lipofectin, but a great part of the oligonucleotide /lipofectin complex appeared to be accumulated at the cell surface ( Fig  2C ) . The best results were achieved by increasing the amount of oligonucleotide up to 10 M and by adding the CatB  GATCTAGGATCCGGCTTC  GTCAGAGATGGCTTCCAC  379  56  CatL  TGGCAACGAGAGCGTCTA  TCCACTTGGTCCACTGTG  238  54  CatK  TCCATCAGCAGGATGTGG  GGCTCTACCTTCCCATTC  358  54  CatX  ACTGGCGCAATGTGGATG  GATGGCGTGGCACTCTTT  347  56  CatF  CATCCAGACAACAGAAAC  TCCAGTCCCATTCAGGTG  370 oligonucleotides without lipofectin every 48 hours to the culture medium to obtain stable conditions over 1 week ( Fig 2D ) .
Effect of antisense oligonucleotides on cathepsin L mRNA and protein expression
The six antisense oligonucleotides were initially screened for their ability to decrease the cathepsin L mRNA levels in MNNG / HOS cells ( Fig 3) . Cells were retreated 48 hours after initial exposure to oligonucleotides. When levels of cathepsin L mRNA were determined 24 hours after this second treatment by Northern blot analysis, a reduced mRNA level for cathepsin L was detected for all antisense oligonucleotides. Addition of the oligonucleotide directed toward the intron ±exon junction ( asCL -4 ) resulted in the lowest concentration of target mRNA (25% ). Transfection with the nonsense ODN did not alter the cathepsin mRNA level. Expression of cathepsins B, K, X, and F, determined by quantitative RT-PCR on the LightCycler, was not affected ( Table 3 ) .
To determine the effect of antisense oligonucleotides at the cathepsin L antigen level, we analyzed the cell homogenates in an ELISA assay. The cathepsin L protein level in antisense -modified cells was significantly reduced to 70% by asCL -4, as compared with the parental cell line and the control ( Fig 4 ) .
In vitro adhesion assay
This procedure constitutes one step of the metastatic process, namely cellular adhesion to basement membranes. The adhesive capacity of the parental and the antisense modified MNNG /HOS cells on collagen I matrices was analyzed after an incubation time of 45 minutes. As seen in Table 3 , adhesion of MNNG /HOS cells was not influenced by transfection of antisense cathepsin L oligonucleotides. The cellular adhesion to the matrices of matrigel and fibronectin was lower than that to collagen I, but the antisense modified cells also failed to show a tendency toward lower adhesion ( Table 4 ) .
In vitro motility and invasion assay
To assess the involvement of cathepsin L in cellular motility and invasion, in vitro assays were performed that reproduce the in vivo situation in the metastatic cascade. We tested whether the MNNG /HOS and the antisense modified tumor cells were able to migrate through the uncoated polycarbonate filters ( motility ) within 24 hours and through the matrigel -coated membranes ( invasion ) within 72 hours. The addition of the antisense oligonucleotides to the MNNG / HOS cells led to a strong inhibitory effect on both the cellular motility and invasion. Identical treatment with the corresponding nonsense oligonucleotide produced only a marginal effect. The best effect was obtained by the oligonucleotide directed against the intron± exon junction ( asCL -4 ), which also shows the lowest expression of the cathepsin L protein. Cellular motility of the modified cells was significantly reduced by 70%, and the invasion through matrigel -coated membranes by 60%. Overall, the lowest inhibitory potential was monitored for the antisense oligonucleotide directed to the 3 H untranslated region ( Figs  5 and 6 ). Figure 6 . In vitro invasion assay. Cellular invasion of MNNG / HOS and antisense transfected cells measured in matrigel -coated transwell chambers ( 8 -m pore size ). Antisense treatment was performed for 5 days by adding 10 M oligonucleotides at intervals of 48 hours before the assay. Invading cells were harvested from the lower side of the filters by using trypsin / EDTA and counted. The differences between MNNG / HOS cells and antisense -modified cells were statistically significant ( two -tailed, unpaired t test; P < .05 ). Bars, mean SD. Cellular adhesion of 1Â10 5 parental and modified cells was determined for 30 minutes on matrices of 10 g/mL collagen I and matrigel. After stringent washing steps, adherent cells were harvested with trypsin/EDTA, and the cell number was quantified in a coulter counter. 1Â10 5 cells were defined as 100%. The adhesion behavior was comparable for all cell clones. 
DISCUSSION
Cysteine proteases are considered to represent the major determinants of the invasive phenotype of tumor cells. 18 ± 22 In contrast to cathepsin B, cathepsin L has not yet been thoroughly studied in different tumor entities. 23, 24 The specificity and sensitivity of the methods used have caused some problems in similar studies investigating cysteine proteases. The high sequence homologies made it difficult for us to find specific synthetic substrates and inhibitors particularly for cathepsin L. Furthermore, ELISA or activity assays in tissue homogenates do not distinguish between the different parts of the tumor. Therefore, the results should be interpreted and compared only after careful considerations.
In the present study, we examined the inhibitory effects of cathepsin L antisense phosphorothioate oligonucleotides on both the expression of cathepsin L and the invasive potential of the human osteosarcoma cell line MNNG / HOS. Antisense oligonucleotides have proved to be useful tools for dissecting gene functions and have the potential for providing a novel approach to cancer therapy. 25, 26 The selection of the target sequences is a critical step. The translation initiation site has been considered to be the best target site for antisense oligonucleotides for several years. 27, 28 However, more recent data demonstrating the migration of oligonucleotides into the nucleus allow us to use oligonucleotides directed against nuclear events, such as mRNA splicing or transport. Considering these facts, we chose six antisense oligonucleotides directed against several regions of the target cathepsin L mRNA, starting with the 5 H untranslated region and ending with the 3 H part of the cathepsin L mRNA. Phosphorothioate oligonucleotides were chosen to prolong the intracellular half -life of the oligonucleotides. Furthermore, they are able to form a duplex with the complementary RNA, which is cleavable by RNase H, one of the predominant mechanisms of antisense inhibition. 29 The addition of all selected antisense oligonucleotides resulted in a reduced cathepsin L expression. However, the antisense oligonucleotide directed against an intron ±exon junction was most effective. Owing to the toxicity of the cationic lipids, we preferred multiple treatment with oligonucleotides, which revealed no changes in tumor cell proliferation. This was an important starting point for the functional assays of cellular adhesion, motility, and invasion.
The lysosomal cysteine protease cathepsin L has been shown to be associated with tumor invasion and metastasis in different tumor entities. Most studies focus on the prognostic value of cathepsin L in a single tumor type, 8 ± 12 whereas only a small number of reports deal with the functional importance of cathepsin L for the different steps of the metastatic cascade. 14, 16 Enhanced expression of cathepsin L was found in metastatic bone tumors 24 as well as in non ± small cell lung cancer, 9 breast cancer, 12 gliomas, 23 and colorectal cancer. 22 In this study, we were able to demonstrate for the first time that cathepsin L is involved in the metastatic process of osteosarcoma cells. Interestingly, the cellular adhesion to protein matrices of collagen I and matrigel was not affected by the reduced level of cathepsin L, whereas cellular motility and invasion were significantly reduced in all antisense -modified MNNG /HOS cells as compared with the parental cell line and the control. These findings are supported by a recent study on the specific antisense inhibition of cathepsin L by cDNA transfection in myeloma cells, with reduced tumor growth in nude mice being the outcome. Overexpression of procathepsin L in melanoma cells increased the tumorigenicity in nude mice and switched their phenotype from nonmetastatic cells to highly metastatic cells. 30 Besides the direct proteolytic activity against components of the basement membrane, cathepsin L takes part in the complex proteolytic activation cascades, including u-PA, other cathepsins, and matrix metalloproteases. Several studies investigating these enzyme groups demonstrated that this proteolytic network constitutes an essential factor in invasive processes. The combination of cathepsin B, u-PA, and cathepsin L promotes the invasiveness in MNNG / HOS osteosarcoma cells. Inhibition of cathepsin B, which regarding function and structure shows considerable homologies to cathepsin L, resulted in a significantly decreased cellular motility and invasion of the osteosarcoma cells. 31 In previous studies, u-PA was also found to be a major component for cellular motility and invasion as well as for cellular adhesion. 32 These facts underline the results obtained for cathepsin L and demonstrate that several proteases act sequentially or simultaneously in the dissolution of basement membranes.
The spectrum of natural substrates of cysteine proteases, together with the morphological findings and the results of the in vitro findings in functional assays, suggest an important role of cathepsin L in malignancy. The importance of proteases and their receptors has triggered an extensive search for antiprotease drugs for cancer therapy. The results obtained in clinical trials are promising.
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